129 related articles for article (PubMed ID: 37433700)
21. Serum insulin-like growth factor binding protein-3 as a potential biomarker for diagnosis and prognosis of oesophageal squamous cell carcinoma.
Luo Y; Hong CQ; Huang BL; Ding TY; Chu LY; Zhang B; Qu QQ; Li XH; Liu CT; Peng YH; Guo HP; Xu YW
Ann Med; 2022 Dec; 54(1):2153-2166. PubMed ID: 35930383
[TBL] [Abstract][Full Text] [Related]
22. Bioinformatics identification of lncRNA biomarkers associated with the progression of esophageal squamous cell carcinoma.
Yu J; Wu X; Huang K; Zhu M; Zhang X; Zhang Y; Chen S; Xu X; Zhang Q
Mol Med Rep; 2019 Jun; 19(6):5309-5320. PubMed ID: 31059058
[TBL] [Abstract][Full Text] [Related]
23. Anti-CDC25B autoantibody predicts poor prognosis in patients with advanced esophageal squamous cell carcinoma.
Dong J; Zeng BH; Xu LH; Wang JY; Li MZ; Zeng MS; Liu WL
J Transl Med; 2010 Sep; 8():81. PubMed ID: 20813067
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of a panel of tumor-associated antigens in breast cancer.
Pagaza-Straffon C; Marchat LA; Herrera L; Díaz-Chávez J; Avante MG; Rodríguez YP; Arreola MC; López-Camarillo C
Cancer Biomark; 2020; 27(2):207-211. PubMed ID: 31839604
[TBL] [Abstract][Full Text] [Related]
25. Autoantibody against Tumor-Associated Antigens as Diagnostic Biomarkers in Hispanic Patients with Hepatocellular Carcinoma.
Ma Y; Qiu C; Wang B; Zhang X; Wang X; Aguilera RJ; Zhang JY
Cells; 2022 Oct; 11(20):. PubMed ID: 36291095
[TBL] [Abstract][Full Text] [Related]
26. A RASSF8-AS1 based exosomal lncRNAs panel used for diagnostic and prognostic biomarkers for esophageal squamous cell carcinoma.
Xie K; Zheng C; Gu W; Jiang Z; Luo C; Luo J; Diao Y; Wang G; Cong Z; Yao X; Hu L; Shen Y
Thorac Cancer; 2022 Dec; 13(23):3341-3352. PubMed ID: 36266257
[TBL] [Abstract][Full Text] [Related]
27. A novel immunodiagnosis panel for hepatocellular carcinoma based on bioinformatics and the autoantibody-antigen system.
Wu J; Wang P; Han Z; Li T; Yi C; Qiu C; Yang Q; Sun G; Dai L; Shi J; Wang K; Ye H
Cancer Sci; 2022 Feb; 113(2):411-422. PubMed ID: 34821436
[TBL] [Abstract][Full Text] [Related]
28. Establishment and validation of an immunodiagnostic model for prediction of breast cancer.
Qiu C; Wang P; Wang B; Shi J; Wang X; Li T; Qin J; Dai L; Ye H; Zhang J
Oncoimmunology; 2020; 9(1):1682382. PubMed ID: 32002291
[TBL] [Abstract][Full Text] [Related]
29. Immunodiagnostic value of combined detection of autoantibodies to tumor-associated antigens as biomarkers in pancreatic cancer.
Li J; Wang LJ; Ying X; Han SX; Bai E; Zhang Y; Zhu Q
Scand J Immunol; 2012 Mar; 75(3):342-9. PubMed ID: 22010875
[TBL] [Abstract][Full Text] [Related]
30. Detection of autoantibodies to a panel of tumor-associated antigens for the diagnosis values of gastric cardia adenocarcinoma.
Zhou SL; Ku JW; Fan ZM; Yue WB; Du F; Zhou YF; Liu YL; Li Y; Tang S; Hu YL; Hu XP; Hou ZC; Liu J; Liu Y; Feng XS; Wang LD
Dis Esophagus; 2015; 28(4):371-9. PubMed ID: 24612004
[TBL] [Abstract][Full Text] [Related]
31. Serological proteome analysis approach-based identification of ENO1 as a tumor-associated antigen and its autoantibody could enhance the sensitivity of CEA and CYFRA 21-1 in the detection of non-small cell lung cancer.
Dai L; Qu Y; Li J; Wang X; Wang K; Wang P; Jiang BH; Zhang J
Oncotarget; 2017 May; 8(22):36664-36673. PubMed ID: 28456790
[TBL] [Abstract][Full Text] [Related]
32. Autoantibodies as potential biomarkers for the early detection of esophageal squamous cell carcinoma.
Xu YW; Peng YH; Chen B; Wu ZY; Wu JY; Shen JH; Zheng CP; Wang SH; Guo HP; Li EM; Xu LY
Am J Gastroenterol; 2014 Jan; 109(1):36-45. PubMed ID: 24296751
[TBL] [Abstract][Full Text] [Related]
33. Development and Validation of an Esophageal Squamous Cell Carcinoma Detection Model by Large-Scale MicroRNA Profiling.
Sudo K; Kato K; Matsuzaki J; Boku N; Abe S; Saito Y; Daiko H; Takizawa S; Aoki Y; Sakamoto H; Niida S; Takeshita F; Fukuda T; Ochiya T
JAMA Netw Open; 2019 May; 2(5):e194573. PubMed ID: 31125107
[TBL] [Abstract][Full Text] [Related]
34. Identification and Evaluation of Autoantibody to a Novel Tumor-Associated Antigen GNA11 as a Biomarker in Esophageal Squamous Cell Carcinoma.
Wang H; Yang X; Sun G; Yang Q; Cui C; Wang X; Ye H; Dai L; Shi J; Zhang J; Wang P
Front Oncol; 2021; 11():661043. PubMed ID: 34568004
[TBL] [Abstract][Full Text] [Related]
35. Identification of diagnostic markers and lipid dysregulation in oesophageal squamous cell carcinoma through lipidomic analysis and machine learning.
Yuan Y; Zhao Z; Xue L; Wang G; Song H; Pang R; Zhou J; Luo J; Song Y; Yin Y
Br J Cancer; 2021 Aug; 125(3):351-357. PubMed ID: 33953345
[TBL] [Abstract][Full Text] [Related]
36. Discovering novel lung cancer associated antigens and the utilization of their autoantibodies in detection of lung cancer.
Pei L; Liu H; Ouyang S; Zhao C; Liu M; Wang T; Wang P; Ye H; Wang K; Song C; Zhang J; Dai L
Immunobiology; 2020 Mar; 225(2):151891. PubMed ID: 31839396
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of serum autoantibodies against tumor-associated antigens as biomarkers in lung cancer.
Li P; Shi JX; Xing MT; Dai LP; Li JT; Zhang JY
Tumour Biol; 2017 Oct; 39(10):1010428317711662. PubMed ID: 29022480
[TBL] [Abstract][Full Text] [Related]
38. Using Serological Proteome Analysis to Identify Serum Anti-Nucleophosmin 1 Autoantibody as a Potential Biomarker in European-American and African-American Patients With Prostate Cancer.
Dai L; Li J; Xing M; Sanchez TW; Casiano CA; Zhang JY
Prostate; 2016 Nov; 76(15):1375-86. PubMed ID: 27418398
[TBL] [Abstract][Full Text] [Related]
39. A panel of autoantibodies against tumor-associated antigens in the early immunodiagnosis of lung cancer.
Jiang D; Wang Y; Liu M; Si Q; Wang T; Pei L; Wang P; Ye H; Shi J; Wang X; Song C; Wang K; Dai L; Zhang J
Immunobiology; 2020 Jan; 225(1):151848. PubMed ID: 31980218
[TBL] [Abstract][Full Text] [Related]
40. Autoantibodies response to MDM2 and p53 in the immunodiagnosis of esophageal squamous cell carcinoma.
Chai Y; Peng B; Dai L; Qian W; Zhang Y; Zhang JY
Scand J Immunol; 2014 Nov; 80(5):362-8. PubMed ID: 24965442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
